175 related articles for article (PubMed ID: 35134165)
1. Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.
Fisher BT; Boge CLK; Xiao R; Shuster S; Chin-Quee D; Allen J; Shaheen S; Hayden R; Suganda S; Zaoutis TE; Chang YC; Yin DE; Huppler AR; Danziger-Isakov L; Muller WJ; Roilides E; Romero J; Sue PK; Berman D; Wattier RL; Halasa N; Pong A; Maron G; Soler-Palacin P; Hutto SC; Gonzalez BE; Salvatore CM; Rajan S; Green M; Doby Knackstedt E; Hauger SB; Steinbach WJ
Clin Infect Dis; 2022 Aug; 75(2):248-259. PubMed ID: 35134165
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Assessment of Four Antigen Assays for the Detection of Invasive Candidiasis Among High-Risk Hospitalized Patients.
Hartl B; Zeller I; Manhart A; Selitsch B; Lass-Flörl C; Willinger B
Mycopathologia; 2018 Jun; 183(3):513-519. PubMed ID: 29356937
[TBL] [Abstract][Full Text] [Related]
3. Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy.
Lunel FM; Donnelly JP; van der Lee HA; Blijlevens NM; Verweij PE
Med Mycol; 2011 Nov; 49(8):848-55. PubMed ID: 21619440
[TBL] [Abstract][Full Text] [Related]
4. Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.
Held J; Kohlberger I; Rappold E; Busse Grawitz A; Häcker G
J Clin Microbiol; 2013 Apr; 51(4):1158-64. PubMed ID: 23363830
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
[TBL] [Abstract][Full Text] [Related]
6. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
Muñoz P; Vena A; Machado M; Gioia F; Martínez-Jiménez MC; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Fernández-Ruiz M; Merino P; González-Romo F; Frías I; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv6-iv12. PubMed ID: 29608751
[TBL] [Abstract][Full Text] [Related]
7. Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation.
Levesque E; El Anbassi S; Sitterle E; Foulet F; Merle JC; Botterel F
J Clin Microbiol; 2015 Mar; 53(3):771-6. PubMed ID: 25520448
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing Invasive Candidiasis.
Clancy CJ; Nguyen MH
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29444828
[TBL] [Abstract][Full Text] [Related]
9. Detection of candidaemia in patients with and without underlying haematological disease.
Arendrup MC; Bergmann OJ; Larsson L; Nielsen HV; Jarløv JO; Christensson B
Clin Microbiol Infect; 2010 Jul; 16(7):855-62. PubMed ID: 20002683
[TBL] [Abstract][Full Text] [Related]
10. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
Nguyen MH; Wissel MC; Shields RK; Salomoni MA; Hao B; Press EG; Shields RM; Cheng S; Mitsani D; Vadnerkar A; Silveira FP; Kleiboeker SB; Clancy CJ
Clin Infect Dis; 2012 May; 54(9):1240-8. PubMed ID: 22431804
[TBL] [Abstract][Full Text] [Related]
11. T2Candida Assay in the Diagnosis of Intraabdominal Candidiasis: A Prospective Multicenter Study.
Krifors A; Ullberg M; Castegren M; Petersson J; Sparrelid E; Hammarström H; Sjölin J; Özenci V; Blennow O
J Fungi (Basel); 2022 Jan; 8(1):. PubMed ID: 35050026
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of T2Candida Among ICU Patients With Risk Factors for Invasive Candidiasis.
Arendrup MC; Andersen JS; Holten MK; Krarup KB; Reiter N; Schierbeck J; Helleberg M
Open Forum Infect Dis; 2019 May; 6(5):ofz136. PubMed ID: 31069244
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the performance level of Candida mannan antigen testing in allogeneic stem cell transplant recipients not receiving fluconazole prophylaxis.
Nihtinen A; Anttila VJ; Richardson M; Ruutu T; Juvonen E; Meri T; Volin L
Transpl Infect Dis; 2011 Jun; 13(3):266-72. PubMed ID: 21176021
[TBL] [Abstract][Full Text] [Related]
14. T2Candida magnetic resonance in patients with invasive candidiasis: Strengths and limitations.
Zurl C; Prattes J; Zollner-Schwetz I; Valentin T; Rabensteiner J; Wunsch S; Hoenigl M; Krause R
Med Mycol; 2020 Jul; 58(5):632-638. PubMed ID: 31613367
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
Alam FF; Mustafa AS; Khan ZU
BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
[TBL] [Abstract][Full Text] [Related]
16. Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species.
Mokaddas E; Burhamah MH; Khan ZU; Ahmad S
BMC Infect Dis; 2010 Oct; 10():292. PubMed ID: 20923575
[TBL] [Abstract][Full Text] [Related]
17. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
[TBL] [Abstract][Full Text] [Related]
18. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
[TBL] [Abstract][Full Text] [Related]
19. Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.
Clancy CJ; Pappas PG; Vazquez J; Judson MA; Kontoyiannis DP; Thompson GR; Garey KW; Reboli A; Greenberg RN; Apewokin S; Lyon GM; Ostrosky-Zeichner L; Wu AHB; Tobin E; Nguyen MH; Caliendo AM
Clin Infect Dis; 2018 May; 66(11):1678-1686. PubMed ID: 29438475
[TBL] [Abstract][Full Text] [Related]
20. [Experience with the Platelia Candida ELISA for the diagnostics of invasive candidosis in neutropenic patients].
Rimek D; Redetzke K; Steiner B; Podbielski A
Mycoses; 2004; 47 Suppl 1():27-31. PubMed ID: 15667361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
